Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
2.
Sci Rep ; 10(1): 13394, 2020 08 07.
Article in English | MEDLINE | ID: mdl-32770125

ABSTRACT

Computed tomography imaging plays a major role in the preoperative assessment of tumor burden by providing an accurate mapping of the distribution of peritoneal metastases (PM). Spectral Photon Counting Computed Tomography (SPCCT) is an innovative imaging modality that could overcome the current limitations of conventional CT, offering not only better spatial resolution but also better contrast resolution by allowing the discrimination of multiple contrast agents. Based on this capability, we tested the feasibility of SPCCT in the detection of PM at different time of tumor growth in 16 rats inoculated with CC531 cells using dual-contrast injection protocols in two compartments (i.e. intravenous iodine and intraperitoneal gadolinium or the reverse protocol), compared to surgery. For all peritoneal regions and for both protocols, sensitivity was 69%, specificity was 100% and accuracy was 80%, and the correlation with surgical exploration was strong (p = 0.97; p = 0.0001). No significant difference was found in terms of diagnostic performance, quality of peritoneal opacification or diagnostic quality between the 2 injection protocols. We also showed poor vascularization of peritoneal metastases by measuring low concentrations of contrast agent in the largest lesions using SPCCT, which was confirmed by immunohistochemical analyses. In conclusion, SPCCT using dual-contrast agent injection protocols in 2 compartments is a promising imaging modality to assess the extent of PM in a rat model.


Subject(s)
Colorectal Neoplasms/pathology , Peritoneal Neoplasms/diagnostic imaging , Peritoneal Neoplasms/secondary , Photons , Tomography, X-Ray Computed/methods , Animals , Cell Line, Tumor , Contrast Media , Disease Models, Animal , Gadolinium , Male , Neoplasm Transplantation , Rats, Inbred Strains , Sensitivity and Specificity
3.
J Vasc Interv Radiol ; 31(6): 917-924, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32376175

ABSTRACT

PURPOSE: To evaluate the safety and efficacy of cryoneurolysis (CNL) in patients with refractory thoracic neuropathic pain related to tumor invasion. MATERIALS AND METHODS: Between January 2013 and May 2017, this single-center and retrospective study reviewed 27 computed tomography-guided CNLs performed on 26 patients for refractory thoracic neuropathic pain related to tumor invasion. Patients with cognitive impairment were excluded. Pain levels were recorded on a visual analog scale (VAS) before the procedure, on days 1, 7, 14, 28 and at each subsequent follow-up appointment. CNL was clinically successful if the postprocedural VAS decreased by 3 points or more. To determine the duration of clinical success, the end of pain relief was defined as either an increased VAS of 2 or more points, the introduction of a new analgesic treatment, a death with controlled pain, or for lost to follow-up patients, the latest follow-up appointment date with controlled pain. RESULTS: Technical success rate was 96.7% and clinical success rate was 100%. Mean preprocedural pain score was 6.4 ± 1.7 and decreased to 2.4 ± 2.4 at day 1; 1.8 ± 1.7 at day 7 (P < .001); 3.3 ± 2.5 at day 14; 3.4 ± 2.6 at day 28 (P < .05). The median duration of pain relief was 45 days (range 14-70). Two minor complications occurred. CONCLUSIONS: Cryoneurolysis is a safe procedure that significantly decreased pain scores in patients with thoracic neuropathic pain related to tumor invasion, with a median duration of clinical success of 45 days.


Subject(s)
Cryosurgery , Denervation/methods , Neoplasms/complications , Neuralgia/surgery , Pain Management/methods , Pain, Intractable/surgery , Thoracic Nerves/surgery , Adolescent , Adult , Aged , Cryosurgery/adverse effects , Denervation/adverse effects , Female , Humans , Male , Middle Aged , Neoplasm Invasiveness , Neoplasms/diagnostic imaging , Neoplasms/pathology , Neuralgia/diagnosis , Neuralgia/etiology , Neuralgia/physiopathology , Pain Management/adverse effects , Pain Measurement , Pain, Intractable/diagnosis , Pain, Intractable/etiology , Pain, Intractable/physiopathology , Retrospective Studies , Thoracic Nerves/diagnostic imaging , Thoracic Nerves/physiopathology , Time Factors , Treatment Outcome , Young Adult
4.
Acta Diabetol ; 56(4): 441-448, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30284618

ABSTRACT

AIMS: Programmed cell death-1 and programmed death ligand 1 (PD-1/PD-L1) inhibitors restore antitumor immunity, but many autoimmune side-effects have been described. Diabetes mellitus is a rare complication, and little data concerning its pathophysiology and phenotype have been published. This study aimed to describe both pancreatic endocrine and exocrine functions, immunological features and change in pancreas volume in subjects with diabetes mellitus induced by PD-1 and PD-L1 inhibitors. METHODS: We analyzed the data of six subjects treated with immunotherapy who presented acute diabetes. RESULTS: There were five men and one woman. Median age was 67 years (range 55-83). Three subjects were treated with nivolumab, two with pembrolizumab and one with durvalumab. Median time to diabetes onset after immunotherapy initiation was 4 months (range 2-13). Four patients presented fulminant diabetes (FD); none of these had type 1 diabetes (T1D)-related autoantibodies, none of them had T1D or FD-very high-risk HLA class II profiles. The bi-hormonal endocrine and exocrine pancreatic failure previously reported for one FD patient was not found in other FD subjects, but glucagon response was blunted in another FD patient. Pancreas volume was decreased at diabetes onset in 2 FD patients, and all patients presented a subsequent decrease of pancreas volume during follow-up. CONCLUSIONS: In the patients presented herein, immunotherapy-induced diabetes was not associated with T1D-related autoantibodies. The hormonal and morphological analysis of the pancreatic glands of these six cases contributes to the understanding of the underlying and probably heterogeneous mechanisms. There is a need to find biomarkers to identify patients at risk to develop these new forms of diabetes at early stages of the process to prevent ketoacidosis and to evaluate preventive strategies.


Subject(s)
B7-H1 Antigen/immunology , Diabetes Mellitus/chemically induced , Immunotherapy/adverse effects , Islets of Langerhans/drug effects , Pancreas, Exocrine/drug effects , Programmed Cell Death 1 Receptor/immunology , Aged , Aged, 80 and over , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal, Humanized/adverse effects , Autoantibodies/blood , B7-H1 Antigen/antagonists & inhibitors , Diabetes Mellitus/pathology , Female , Humans , Islets of Langerhans/metabolism , Islets of Langerhans/pathology , Male , Middle Aged , Nivolumab/adverse effects , Pancreas, Exocrine/metabolism , Pancreas, Exocrine/pathology , Phenotype , Programmed Cell Death 1 Receptor/antagonists & inhibitors
5.
Semin Intervent Radiol ; 35(4): 281-289, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30402011

ABSTRACT

The prevalence of patients with painful bone metastases is constantly increasing. This is related to the rising incidence of cancer and increasing life expectancy of patients with metastatic stage. Advances in imaging and development of percutaneous techniques have gradually allowed offering minimally invasive acts on these metastases: cementing, vertebral augmentation, osteosynthesis, percutaneous thermal ablation, neurolysis, embolization. The purpose of this article is to present the main tools available to date for the interventional radiologist so that each participant can understand their functioning, indications, and limits.

6.
Clin Sarcoma Res ; 8: 22, 2018.
Article in English | MEDLINE | ID: mdl-30473763

ABSTRACT

BACKGROUND: Review of the first documented case of aortic wall metastasis from a limb sarcoma. CASE PRESENTATION: In a 56-year-old woman with a diagnosis of a high-grade limb fibrosarcoma, an aortic metastasis was revealed by a fast growing aneurysm of the descending thoracic aorta. This was managed with an endoprosthesis. CONCLUSION: The presence of an aneurysm in a patient with a sarcoma with a high potential for metastasis and poor cardiovascular risk factors should alert physicians.

7.
Invest Radiol ; 53(10): 629-639, 2018 10.
Article in English | MEDLINE | ID: mdl-29794948

ABSTRACT

OBJECTIVES: To validate in vitro the capability of a high-spatial-resolution prototype spectral photon-counting computed tomography (SPCCT) scanner to differentiate between 2 contrast agents and to assess in vivo the image quality and the feasibility to image the peritoneal cavity in rats using the 2 contrast agents simultaneously within the vascular and peritoneal compartments. MATERIALS AND METHODS: The authors performed SPCCT imaging (100 mAs, 120 kVp) with energy bin thresholds set to 30, 51, 64, 72, and 85 keV in vitro on a custom-made polyoxymethylene cylindrical phantom consisting of tubes with dilutions of both contrast agents and in vivo on 2 groups of adult rats using 2 injection protocols. Approval from the institutional animal ethics committee was obtained. One group received macrocylic gadolinium chelate intraperitoneal (IP) and iodine intravenous (IV) injections (protocol A, n = 3), whereas the second group received iodine IP and gadolinium IV (protocol B, n = 3). Helical scans were performed 35 minutes after IP injection and 20 seconds after IV injection. The SPCCT and contrast material images, that is, iodine and gadolinium maps, were reconstructed with a field of view of 160 mm, an isotropic voxel size of 250 µm, and a matrix size of 640 × 640 pixels using a soft reconstruction kernel. The SPCCT images were reconstructed with 2 different spatial resolutions to compare the image quality (sharpness, diagnostic quality, and organ visualization) of SPCCT (250 µm) with single-energy computed tomography (CT) (600 µm). Two radiologists evaluated the peritoneal opacification index in 13 regions (score = 0-3 per region) on each type of image. Concentrations of contrast agents were measured in the organs of interest. RESULTS: In vitro, the concentration measurements correlated well with the expected concentrations. The linear regressions both had R values of 0.99, slopes of 0.84 and 0.87, and offsets at -0.52 and -0.38 mg/mL for iodine and gadolinium, respectively. In vivo, the SPCCT images were of better diagnostic quality, with increased sharpness compared with the CT-like images (P < 0.0001). Intraperitoneal diffusion was excellent, with similar peritoneal opacification index on SPCCT images and overlay of contrast material maps (P = 1) without a significant difference between protocol A (37.0 ± 1.7) and protocol B (35.3 ± 1.5) (P = 0.34). Only the contrast material maps demonstrated clear visual separation of the contrast agents, allowing specific quantification of the physiological enhancement in the liver, spleen, and kidney and the urinary clearance in the renal pelvis and bladder. Renal excretion of the contrast agents injected IP was observed and was consistent with blood diffusion. CONCLUSIONS: Spectral photon-counting CT can be used to perform a complete peritoneal dual-contrast protocol, enabling a good assessment of the peritoneal cavity and abdominal organs in rats.


Subject(s)
Abdomen/diagnostic imaging , Contrast Media , Peritoneal Cavity/diagnostic imaging , Radiographic Image Enhancement/methods , Tomography, Emission-Computed, Single-Photon/methods , Animals , Gadolinium , Humans , Image Processing, Computer-Assisted/methods , Iodine , Linear Models , Male , Models, Animal , Phantoms, Imaging , Photons , Rats , Rats, Sprague-Dawley , Reproducibility of Results
9.
Cardiovasc Intervent Radiol ; 41(2): 340-343, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28913628

ABSTRACT

Percutaneous tumor ablations are rather safe and effective treatments in selected patients for non-operable non-small cell lung carcinomas or lung metastases. However, there are major complications such as bronchopleural or bronchocutaneous fistula, which it is important to know in order to manage them safely. We describe in this report a case of bronchocutaneous fistula without pneumothorax following a microwave ablation of a recurrent pulmonary metastasis and its management.


Subject(s)
Ablation Techniques/adverse effects , Breast Neoplasms/pathology , Bronchial Fistula/etiology , Cutaneous Fistula/etiology , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Postoperative Complications/etiology , Ablation Techniques/methods , Bronchial Fistula/diagnostic imaging , Cutaneous Fistula/diagnostic imaging , Female , Humans , Microwaves , Middle Aged , Pneumothorax , Postoperative Complications/diagnostic imaging , Recurrence , Time , Tomography, X-Ray Computed , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...